Stocks
ALX Oncology Holdings (ALXO) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | 5 years average | |||
| ROE, % | ? | -23.0% | -46.9% | -84.8% | -118.7% | -391.4% | -58.7% | ||
| Changes by years, y/y, % | -12pp | -24pp | -38pp | -34pp | -273pp | -133% | |||
ALX Oncology Holdings. ROE, %
ALX Oncology Holdings. ROE, changes, pp
ALX Oncology Holdings (ALXO) ROE US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| ROE, % | ? | -181.0% | -241.1% | -391.4% | -58.7% | -59.4% | -58.7% | |
| Changes by years, y/y, % | -73pp | -131pp | -273pp | +89pp | +122pp | |||
| Changes by quarters, q/q, % | -34pp | -60pp | -150pp | +333pp | -1pp | |||
